google.com, pub-8701563775261122, DIRECT, f08c47fec0942fa0
Australia

Probiotic firm hopes for great things from new strain

5 June 2026 13:51 | News

It is a type of probiotic developed by. Australia Biotechnology group for several years produced good results in early trialssays the owner.

Biome Australia has licensed a number of probiotic strains for use in its pills sold under its name in pharmacies across the country.

But the listed biotech company also owns the intellectual property rights to BMB 18, a proprietary strain of L. plantarum, a probiotic widely used for weight loss and improving gut and oral health.

Last financial year, Biome Australia achieved its first net profit of over $214,000. (Joel Carrett/AAP PHOTOS)

The first Petri dish testing showed “certainly one of the strongest results we’ve seen in mechanistic data on immune support on inflammation,” founder and chief executive Blair Vega Norfolk said at an investor briefing on Friday.

A 240-participant clinical trial evaluating BMB 18 began in May at La Trobe University in Melbourne and Harokopio University in Athens, with the aim of generating initial data on the strain’s effectiveness in humans.

“We hope to show really significant p-values ​​and results on gut health and also mental health within the next 12 months,” Mr Norfolk said.

DRUG STOCK
Biome Australia has licensed a number of probiotic strains for use exclusively in its pills. (Lukas Coch/AAP PHOTOS)

Our hope is that Biome Australia will be able to add BMB 18 as a “hero” to some of its existing probiotic strains that sell well, thereby further protecting its intellectual property and brand.

“It will also create a very unique opportunity for us to develop new products in areas where we have no competition,” Mr. Norfolk said.

This strain can also be licensed to some of the world’s leading probiotic manufacturers.

CSIRO CORONAVIRUS PRINTING MACHINE
Our hope is that Biome will be able to add BMB 18 as a “hero” to some of their existing probiotic strains. (David Crosling/AAP PHOTOS)

Biome Australia has a low-single-digit share of Australia’s $600 million probiotic market, with sales of $12.4 million in the first half.

The company says its brands are the leading probiotics in community pharmacies and number 2 in the Terry White Chemmart chain.

Last financial year, Biome Australia achieved its first net profit of $214,656.


AAP News

Australia’s Associated Press is the beating heart of Australian news. AAP is Australia’s only independent national news channel and has been providing accurate, reliable and fast-paced news content to the media industry, government and corporate sector for 85 years. We inform Australia.

Latest stories from our writers

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button